Smith Group Asset Management LLC Makes New $612,000 Investment in The Allstate Corporation $ALL

Smith Group Asset Management LLC bought a new position in The Allstate Corporation (NYSE:ALLFree Report) in the second quarter, Holdings Channel.com reports. The institutional investor bought 3,040 shares of the insurance provider’s stock, valued at approximately $612,000.

A number of other large investors have also added to or reduced their stakes in the company. Vanguard Group Inc. raised its holdings in Allstate by 0.5% in the first quarter. Vanguard Group Inc. now owns 32,800,086 shares of the insurance provider’s stock worth $6,791,914,000 after purchasing an additional 164,662 shares in the last quarter. Price T Rowe Associates Inc. MD raised its holdings in Allstate by 25.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 11,709,610 shares of the insurance provider’s stock worth $2,424,710,000 after purchasing an additional 2,374,684 shares in the last quarter. GQG Partners LLC raised its holdings in Allstate by 2.1% in the first quarter. GQG Partners LLC now owns 4,405,701 shares of the insurance provider’s stock worth $912,288,000 after purchasing an additional 89,185 shares in the last quarter. Boston Partners raised its holdings in Allstate by 613.9% in the first quarter. Boston Partners now owns 2,482,654 shares of the insurance provider’s stock worth $512,627,000 after purchasing an additional 2,134,893 shares in the last quarter. Finally, Goldman Sachs Group Inc. raised its holdings in Allstate by 27.2% in the first quarter. Goldman Sachs Group Inc. now owns 2,328,070 shares of the insurance provider’s stock worth $482,073,000 after purchasing an additional 497,982 shares in the last quarter. 76.47% of the stock is currently owned by institutional investors.

Allstate Price Performance

Shares of NYSE ALL opened at $194.46 on Friday. The business’s 50 day moving average price is $204.54 and its 200 day moving average price is $200.89. The firm has a market cap of $51.24 billion, a P/E ratio of 9.14, a P/E/G ratio of 0.71 and a beta of 0.38. The Allstate Corporation has a 52 week low of $176.00 and a 52 week high of $215.70. The company has a quick ratio of 0.43, a current ratio of 0.43 and a debt-to-equity ratio of 0.37.

Allstate (NYSE:ALLGet Free Report) last issued its earnings results on Wednesday, July 30th. The insurance provider reported $5.94 EPS for the quarter, beating analysts’ consensus estimates of $3.20 by $2.74. Allstate had a return on equity of 28.74% and a net margin of 8.79%.The firm had revenue of $15.05 billion for the quarter, compared to analyst estimates of $16.59 billion. During the same quarter in the prior year, the firm earned $1.61 earnings per share. Allstate’s revenue for the quarter was up 5.8% on a year-over-year basis. On average, sell-side analysts expect that The Allstate Corporation will post 18.74 earnings per share for the current year.

Wall Street Analyst Weigh In

ALL has been the topic of a number of research analyst reports. Barclays restated an “underweight” rating and set a $198.00 price target (up previously from $188.00) on shares of Allstate in a research note on Thursday, July 31st. Jefferies Financial Group boosted their price target on Allstate from $254.00 to $255.00 and gave the stock a “buy” rating in a research note on Monday, August 11th. Evercore ISI set a $233.00 price target on Allstate and gave the stock an “in-line” rating in a research note on Wednesday, October 1st. Weiss Ratings restated a “buy (b)” rating on shares of Allstate in a research note on Wednesday, October 8th. Finally, JPMorgan Chase & Co. boosted their price target on Allstate from $235.00 to $254.00 and gave the stock an “overweight” rating in a research note on Thursday, October 9th. Two research analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Allstate currently has an average rating of “Moderate Buy” and a consensus price target of $234.60.

View Our Latest Analysis on Allstate

Allstate Profile

(Free Report)

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.

Featured Articles

Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Corporation (NYSE:ALLFree Report).

Institutional Ownership by Quarter for Allstate (NYSE:ALL)

Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.